openPR Logo
Press release

Key Sessions during the Highly Potent Active Pharmaceutical Conference Released

02-28-2022 03:59 PM CET | Health & Medicine

Press release from: SMi Group

P-376 PR2

P-376 PR2

SMi's 6th Annual Highly Potent APi Conference will also explore the ADC industry, legal aspects, environmental policy, and how to effectively establish a business case for containment - as well as taking a look to the future of HPAPI as new modalities continue to surface.

Taking place on 9th - 10th May 2022 in London, UK; the conference will focus on a robust scientific approach to handling HPAPI, from hazard identification and exposure limits to toxicological risk assessment, in addition to engineering containment controls, and occupational hygiene testing.

Interested parties can register at: http://www.highlypotentapi.com/PR2OPENPR - register by 28th January 2022 to save £200.

SMi Group have released the key sessions that will be taking place over the two-day conference, see below for an excerpt:

OPENING ADDRESS - Key Elements of [Highly] Potent API Projects
•What is more Important? Product Safety or Worker Safety?
•Higher Potency and Toxicity in Drug Pipelines
•Is SARS-CoV-2 and/or its Vaccines 'Potent'?
•Hazard, Risk and Control (and uncertainty)
•Potent Drug Facility Design
Justin Mason-Home, FRSC, Director/Owner, HPAPI Project Services Ltd

SPOTLIGHT SESSION - Human Behaviours Leading to Safe & Successful Potent Product Manufacturing

•There have been progressive improvements in potent compound containment in Pharma within the last 20 years
•Great sharing of 'best practice', resulting in similar approaches across the sector
•A degree of 'health & safety anxiety' is observed when the API OELs go below 10 mcg/m3
•Expensive Containment infrastructure is only as useful as the human capability interacting with it
•Do we need to look at how we prepare workers handling extremely active, harmful chemical agents?
•This talk examines some of the key human factors that can influence a successful approach to handling potent compounds
Dr. Damien Boyd, Regional Industrial Hygiene (EMEA region), MSD

PANEL DISCUSSION - Highly Potent APIs in Pharma

•How can we ensure compliance with both Good Manufacturing Practice (GMP) and Environmental Health and Safety (EHS)?
•When should engineering controls be employed?
•How should Risk, Hazard, and Uncertainty be treated in this field?
Justin Mason-Home, FRSC, Director/Owner, HPAPI Project Services Ltd
Olindo Lazzaro, Head, Global Occupational Safety, Novartis
Dr. Damien Boyd, Regional Industrial Hygiene (EMEA region), MSD
Richard Denk, Senior Consultant Aseptic Processing & Containment, SKAN AG

OPENING ADDRESS - Trends and Outlook on Containment

•Approaches for effective evaluation of cleaning validation and monitoring
•Fully automated Gloveless Robotic Aseptic Filling Line for high potent substances
•Clean to prevent Cross Contamination
•New ISPE DACH Containment Handbook introduction
Richard Denk, Senior Consultant Aseptic Processing & Containment, SKAN AG

To find out more about the speaker-line up and conference agenda, please visit: http://www.highlypotentapi.com/PR2OPENPR and register by 28th February to save £200.

The 6th Annual Highly Potent APi Conference will enable delegates to expand their community and explore the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading pharmaceutical and biotechnology companies.

For sponsorship enquiries contact Luke Teachen, Business Development Manager on +44 (0) 20 7827 6002 or e-mail lteachen@smi-online.co.uk

For media enquiries or a press pass contact Marketing, Nikisha Galoria on +44 (0) 20 7827 6154 or email ngaloria@smi-online.co.uk

Annual Highly Potent Active Pharmaceutical Ingredients Conference
9 - 10 May 2022
London, UK
#SMiHPAPi
http://www.highlypotentapi.com/PR2OPENPR
--- ENDS ---

India House, 45 Curlew Street

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Key Sessions during the Highly Potent Active Pharmaceutical Conference Released here

News-ID: 2566177 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Potent

Highly Potent Active Pharmaceutical Ingredients Market 2021 | Detailed Report
ReportsnReports publishes the report titled Highly Potent Active Pharmaceutical Ingredients that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital
Highly Potent API Market Size, Share, Development by 2025
Market Research Report Store offers a latest published report on Highly Potent API Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Highly Potent API players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Highly Potent API with respect
Highly Potent API Market: Competitive Dynamics & Global Outlook 2024
LP INFORMATION offers a latest published report on Highly Potent API Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Highly Potent API market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.
Highly Potent API Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Highly Potent API Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Highly Potent API players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Highly Potent API with respect
Highly Potent APIs 2019 Conference: Interview with Bayer Pharma
Dr Ulrich Rüemenapp, Head of Launch Preparation and Coordination at Bayer Pharma, will be discussing late stage CMC development and bio-manufacturing for fast track projects at SMi’s 3rd annual Highly Potent Active Pharmaceutical Ingredients conference. Ahead of the conference next month, SMi interviewed him where he gave his thoughts on how the industry has progressed and what the future holds for the industry. Ulrich said: “From my point of view the hype
Containment for highly potent APIs
This year the GEA Pharma Systems stand at ACHEMA will include the company’s wide range of specialist equipment for processing highly potent compounds providing the highest yields and levels of operator and environmental protection available. Courtoy™ MODUL™ tablet press Centre stage on the stand will be the unique Courtoy™ MODUL™ tablet press with its Exchange Compression Module (ECM) that contains all the product-contact components within a sealed central core that can be